and the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage - Davis, SM; Broderick, J; Hennerici, M (Neurology, 2006)
et al.